P1121 EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALS
| Autor: | Ferenci, P., Dieterich, D., Zeuzem, S., Mantry, P., Sarrazin, C., Crespo, J., Tam, E., Dufour, J.-F., Yoshida, E.M., Nishiguchi, S., Bourlière, M., Omata, M., Abergel, A., Kuboki, M., Carvalho, A., Peng, C.-Y., Romero-Gómez, M., Wright, D., Stern, J.O., Böcher, W., Kukolj, G., Gallivan, J.-P., Scherer, J., Jensen, D.M. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2014 60(1) Supplement:S452-S453 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect